Results 151 to 160 of about 134,905 (296)

Emerging Nanonutraceuticals against Obesity

open access: yesSmall Science, EarlyView.
This overview comprehensively compiles the latest research advancements in diversiform nanonutraceuticals against obesity. These nanonutraceuticals are derived from the nanomodifications of some carbohydrates, lipids, proteins, vitamins, minerals, and phytochemicals.
Linjie Ni   +8 more
wiley   +1 more source

Long-duration leptin transgene expression in dorsal vagal complex does not alter bone parameters in female Sprague Dawley rats

open access: yesBone Reports
The hypothalamus and dorsal vagal complex (DVC) are both important for integration of signals that regulate energy balance. Increased leptin transgene expression in either the hypothalamus or DVC of female rats was shown to decrease white adipose tissue ...
Russell T. Turner   +2 more
doaj  

Leptin and Acute Lung Disorders. [PDF]

open access: yesCompr Physiol
Huertas A, Bhattacharya J.
europepmc   +1 more source

Pathophysiological Significance of theObeseGene Product, Leptin, in Ventromedial Hypothalamus (VMH)-Lesioned Rats: Evidence for Loss of Its Satiety Effect in VMH-Lesioned Rats1 [PDF]

open access: bronze, 1997
Noriko Satoh   +12 more
openalex   +1 more source

Obesity, Leptin and Leptin Receptors

open access: yesGene, Cell and Tissue, 2016
Maryam Shojaee   +2 more
openaire   +2 more sources

Gut Microbiota as a Mediator Between Intestinal Fibrosis and Creeping Fat in Crohn's Disease

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Intestinal stricture remains one of the most challenging complications in Crohn's disease, and its underlying mechanisms are poorly understood. Accumulating evidence suggests that gut microbiota is significantly altered in stenotic intestines and may play a key role in the development of fibrogenesis in Crohn's disease.
Caiguang Liu   +14 more
wiley   +1 more source

Expression of a Leptin Receptor in Immortalized Gonadotropin-Releasing Hormone-Secreting Neurons* [PDF]

open access: bronze, 1999
Paolo Magni   +8 more
openalex   +1 more source

Key Predictors of Relevant Weight Loss in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Background and Aims Weight loss is an effective therapeutic strategy for patients with metabolic dysfunction‐associated steatotic liver disease (MASLD). This study aimed to identify factors that predict relevant weight loss, defined as at least 7% of initial body weight, in MASLD outpatients.
Nicola Pugliese   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy